aav8 cmv egfp virus Search Results


96
Vector Biolabs av 9 27056 aav8 gfap 0 7 egfp t2a icre vector biolabs cat
Av 9 27056 Aav8 Gfap 0 7 Egfp T2a Icre Vector Biolabs Cat, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/av 9 27056 aav8 gfap 0 7 egfp t2a icre vector biolabs cat/product/Vector Biolabs
Average 96 stars, based on 1 article reviews
av 9 27056 aav8 gfap 0 7 egfp t2a icre vector biolabs cat - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

94
Addgene inc aav8 chemicals
Aav8 Chemicals, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aav8 chemicals/product/Addgene inc
Average 94 stars, based on 1 article reviews
aav8 chemicals - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

94
Addgene inc aav8 camkii egfp control viruses
Aav8 Camkii Egfp Control Viruses, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aav8 camkii egfp control viruses/product/Addgene inc
Average 94 stars, based on 1 article reviews
aav8 camkii egfp control viruses - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

90
CdmoGen Co Ltd aav8-egfp
Fluorescence Images of Control and AAV2-, AAV5-, and AAV-8-Injected Eyes Whole mounts of control eyes with (E) or without (A) choroidal neovascularization (CNV) showed only faint autofluorescence around the optic nerve head. In the absence of CNV, eyes injected with AAV2 (B) demonstrated diffuse, scattered fluorescence spots throughout the fundus, while eyes injected with AAV5 (C) or <t>AAV8</t> (D) showed less fluorescence. In eyes with CNV, transduction of AAV of all three serotypes—AAV2 (F), -5 (G), and -8 (H)—was markedly increased around CNV lesions. The increase in transduction of AAV2 was greater than that of the other two serotypes. (I) The relative fluorescence intensities were as follows: AAV2/CNV − (n = 5), 2.45 ± 0.24; AAV2/CNV + (n = 10), 3.93 ± 0.32; AAV5/CNV − (n = 5), 1.88 ± 0.17; AAV5/CNV + (n = 10), 3.20 ± 0.19; AAV8/CNV − (n = 5), 2.07 ± 0.21; AAV8/CNV + (n = 10), 3.43 ± 0.21 (I). In the absence of CNV, there were significant differences in fluorescence intensity between control eyes and eyes injected with AAV (AAV2/CNV − , AAV5/CNV − , and AAV8/CNV − ) (p < 0.05). The fluorescence intensity differed significantly between eyes with and without CNV injected with all of the three AAV serotypes (AAV2, p < 0.017; AAV5, p < 0.024; AAV8, p < 0.021). Data are expressed as mean ± SEM. Significant differences: †p < 0.05 versus control eyes, ‡p < 0.05 versus eyes without CNV. Asterisk (*), CNV lesion. Scale bars, 200 μm.
Aav8 Egfp, supplied by CdmoGen Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aav8-egfp/product/CdmoGen Co Ltd
Average 90 stars, based on 1 article reviews
aav8-egfp - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

96
Addgene inc virus strains aav8 tbg pi cre rbg penn vector core addgene 107787 aav8 tbg pi egfp wpre bgh penn vector core addgene 105535 chemicals
Fluorescence Images of Control and AAV2-, AAV5-, and AAV-8-Injected Eyes Whole mounts of control eyes with (E) or without (A) choroidal neovascularization (CNV) showed only faint autofluorescence around the optic nerve head. In the absence of CNV, eyes injected with AAV2 (B) demonstrated diffuse, scattered fluorescence spots throughout the fundus, while eyes injected with AAV5 (C) or <t>AAV8</t> (D) showed less fluorescence. In eyes with CNV, transduction of AAV of all three serotypes—AAV2 (F), -5 (G), and -8 (H)—was markedly increased around CNV lesions. The increase in transduction of AAV2 was greater than that of the other two serotypes. (I) The relative fluorescence intensities were as follows: AAV2/CNV − (n = 5), 2.45 ± 0.24; AAV2/CNV + (n = 10), 3.93 ± 0.32; AAV5/CNV − (n = 5), 1.88 ± 0.17; AAV5/CNV + (n = 10), 3.20 ± 0.19; AAV8/CNV − (n = 5), 2.07 ± 0.21; AAV8/CNV + (n = 10), 3.43 ± 0.21 (I). In the absence of CNV, there were significant differences in fluorescence intensity between control eyes and eyes injected with AAV (AAV2/CNV − , AAV5/CNV − , and AAV8/CNV − ) (p < 0.05). The fluorescence intensity differed significantly between eyes with and without CNV injected with all of the three AAV serotypes (AAV2, p < 0.017; AAV5, p < 0.024; AAV8, p < 0.021). Data are expressed as mean ± SEM. Significant differences: †p < 0.05 versus control eyes, ‡p < 0.05 versus eyes without CNV. Asterisk (*), CNV lesion. Scale bars, 200 μm.
Virus Strains Aav8 Tbg Pi Cre Rbg Penn Vector Core Addgene 107787 Aav8 Tbg Pi Egfp Wpre Bgh Penn Vector Core Addgene 105535 Chemicals, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/virus strains aav8 tbg pi cre rbg penn vector core addgene 107787 aav8 tbg pi egfp wpre bgh penn vector core addgene 105535 chemicals/product/Addgene inc
Average 96 stars, based on 1 article reviews
virus strains aav8 tbg pi cre rbg penn vector core addgene 107787 aav8 tbg pi egfp wpre bgh penn vector core addgene 105535 chemicals - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

90
VectorBuilder GmbH aav8-cmv-egfp
Fluorescence Images of Control and AAV2-, AAV5-, and AAV-8-Injected Eyes Whole mounts of control eyes with (E) or without (A) choroidal neovascularization (CNV) showed only faint autofluorescence around the optic nerve head. In the absence of CNV, eyes injected with AAV2 (B) demonstrated diffuse, scattered fluorescence spots throughout the fundus, while eyes injected with AAV5 (C) or <t>AAV8</t> (D) showed less fluorescence. In eyes with CNV, transduction of AAV of all three serotypes—AAV2 (F), -5 (G), and -8 (H)—was markedly increased around CNV lesions. The increase in transduction of AAV2 was greater than that of the other two serotypes. (I) The relative fluorescence intensities were as follows: AAV2/CNV − (n = 5), 2.45 ± 0.24; AAV2/CNV + (n = 10), 3.93 ± 0.32; AAV5/CNV − (n = 5), 1.88 ± 0.17; AAV5/CNV + (n = 10), 3.20 ± 0.19; AAV8/CNV − (n = 5), 2.07 ± 0.21; AAV8/CNV + (n = 10), 3.43 ± 0.21 (I). In the absence of CNV, there were significant differences in fluorescence intensity between control eyes and eyes injected with AAV (AAV2/CNV − , AAV5/CNV − , and AAV8/CNV − ) (p < 0.05). The fluorescence intensity differed significantly between eyes with and without CNV injected with all of the three AAV serotypes (AAV2, p < 0.017; AAV5, p < 0.024; AAV8, p < 0.021). Data are expressed as mean ± SEM. Significant differences: †p < 0.05 versus control eyes, ‡p < 0.05 versus eyes without CNV. Asterisk (*), CNV lesion. Scale bars, 200 μm.
Aav8 Cmv Egfp, supplied by VectorBuilder GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aav8-cmv-egfp/product/VectorBuilder GmbH
Average 90 stars, based on 1 article reviews
aav8-cmv-egfp - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

93
Addgene inc aav8 hi hsyn cre egfp
Fluorescence Images of Control and AAV2-, AAV5-, and AAV-8-Injected Eyes Whole mounts of control eyes with (E) or without (A) choroidal neovascularization (CNV) showed only faint autofluorescence around the optic nerve head. In the absence of CNV, eyes injected with AAV2 (B) demonstrated diffuse, scattered fluorescence spots throughout the fundus, while eyes injected with AAV5 (C) or <t>AAV8</t> (D) showed less fluorescence. In eyes with CNV, transduction of AAV of all three serotypes—AAV2 (F), -5 (G), and -8 (H)—was markedly increased around CNV lesions. The increase in transduction of AAV2 was greater than that of the other two serotypes. (I) The relative fluorescence intensities were as follows: AAV2/CNV − (n = 5), 2.45 ± 0.24; AAV2/CNV + (n = 10), 3.93 ± 0.32; AAV5/CNV − (n = 5), 1.88 ± 0.17; AAV5/CNV + (n = 10), 3.20 ± 0.19; AAV8/CNV − (n = 5), 2.07 ± 0.21; AAV8/CNV + (n = 10), 3.43 ± 0.21 (I). In the absence of CNV, there were significant differences in fluorescence intensity between control eyes and eyes injected with AAV (AAV2/CNV − , AAV5/CNV − , and AAV8/CNV − ) (p < 0.05). The fluorescence intensity differed significantly between eyes with and without CNV injected with all of the three AAV serotypes (AAV2, p < 0.017; AAV5, p < 0.024; AAV8, p < 0.021). Data are expressed as mean ± SEM. Significant differences: †p < 0.05 versus control eyes, ‡p < 0.05 versus eyes without CNV. Asterisk (*), CNV lesion. Scale bars, 200 μm.
Aav8 Hi Hsyn Cre Egfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aav8 hi hsyn cre egfp/product/Addgene inc
Average 93 stars, based on 1 article reviews
aav8 hi hsyn cre egfp - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

96
Addgene inc control virus aav8 hsyn eyfp
Fluorescence Images of Control and AAV2-, AAV5-, and AAV-8-Injected Eyes Whole mounts of control eyes with (E) or without (A) choroidal neovascularization (CNV) showed only faint autofluorescence around the optic nerve head. In the absence of CNV, eyes injected with AAV2 (B) demonstrated diffuse, scattered fluorescence spots throughout the fundus, while eyes injected with AAV5 (C) or <t>AAV8</t> (D) showed less fluorescence. In eyes with CNV, transduction of AAV of all three serotypes—AAV2 (F), -5 (G), and -8 (H)—was markedly increased around CNV lesions. The increase in transduction of AAV2 was greater than that of the other two serotypes. (I) The relative fluorescence intensities were as follows: AAV2/CNV − (n = 5), 2.45 ± 0.24; AAV2/CNV + (n = 10), 3.93 ± 0.32; AAV5/CNV − (n = 5), 1.88 ± 0.17; AAV5/CNV + (n = 10), 3.20 ± 0.19; AAV8/CNV − (n = 5), 2.07 ± 0.21; AAV8/CNV + (n = 10), 3.43 ± 0.21 (I). In the absence of CNV, there were significant differences in fluorescence intensity between control eyes and eyes injected with AAV (AAV2/CNV − , AAV5/CNV − , and AAV8/CNV − ) (p < 0.05). The fluorescence intensity differed significantly between eyes with and without CNV injected with all of the three AAV serotypes (AAV2, p < 0.017; AAV5, p < 0.024; AAV8, p < 0.021). Data are expressed as mean ± SEM. Significant differences: †p < 0.05 versus control eyes, ‡p < 0.05 versus eyes without CNV. Asterisk (*), CNV lesion. Scale bars, 200 μm.
Control Virus Aav8 Hsyn Eyfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/control virus aav8 hsyn eyfp/product/Addgene inc
Average 96 stars, based on 1 article reviews
control virus aav8 hsyn eyfp - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

93
Addgene inc 119741 aav9 aav8 hsyn fdio hm3d gq mcherrywprepa a gift
Fluorescence Images of Control and AAV2-, AAV5-, and AAV-8-Injected Eyes Whole mounts of control eyes with (E) or without (A) choroidal neovascularization (CNV) showed only faint autofluorescence around the optic nerve head. In the absence of CNV, eyes injected with AAV2 (B) demonstrated diffuse, scattered fluorescence spots throughout the fundus, while eyes injected with AAV5 (C) or <t>AAV8</t> (D) showed less fluorescence. In eyes with CNV, transduction of AAV of all three serotypes—AAV2 (F), -5 (G), and -8 (H)—was markedly increased around CNV lesions. The increase in transduction of AAV2 was greater than that of the other two serotypes. (I) The relative fluorescence intensities were as follows: AAV2/CNV − (n = 5), 2.45 ± 0.24; AAV2/CNV + (n = 10), 3.93 ± 0.32; AAV5/CNV − (n = 5), 1.88 ± 0.17; AAV5/CNV + (n = 10), 3.20 ± 0.19; AAV8/CNV − (n = 5), 2.07 ± 0.21; AAV8/CNV + (n = 10), 3.43 ± 0.21 (I). In the absence of CNV, there were significant differences in fluorescence intensity between control eyes and eyes injected with AAV (AAV2/CNV − , AAV5/CNV − , and AAV8/CNV − ) (p < 0.05). The fluorescence intensity differed significantly between eyes with and without CNV injected with all of the three AAV serotypes (AAV2, p < 0.017; AAV5, p < 0.024; AAV8, p < 0.021). Data are expressed as mean ± SEM. Significant differences: †p < 0.05 versus control eyes, ‡p < 0.05 versus eyes without CNV. Asterisk (*), CNV lesion. Scale bars, 200 μm.
119741 Aav9 Aav8 Hsyn Fdio Hm3d Gq Mcherrywprepa A Gift, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/119741 aav9 aav8 hsyn fdio hm3d gq mcherrywprepa a gift/product/Addgene inc
Average 93 stars, based on 1 article reviews
119741 aav9 aav8 hsyn fdio hm3d gq mcherrywprepa a gift - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

93
Addgene inc virus strains aav8 hsyn jaws kgc gfp er2 wpre hgh addgene 65014 aav8 paav8 hsyn egfp addgene 50465 aav8 chemicals
KEY RESOURCES TABLE
Virus Strains Aav8 Hsyn Jaws Kgc Gfp Er2 Wpre Hgh Addgene 65014 Aav8 Paav8 Hsyn Egfp Addgene 50465 Aav8 Chemicals, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/virus strains aav8 hsyn jaws kgc gfp er2 wpre hgh addgene 65014 aav8 paav8 hsyn egfp addgene 50465 aav8 chemicals/product/Addgene inc
Average 93 stars, based on 1 article reviews
virus strains aav8 hsyn jaws kgc gfp er2 wpre hgh addgene 65014 aav8 paav8 hsyn egfp addgene 50465 aav8 chemicals - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

94
Addgene inc egfp
KEY RESOURCES TABLE
Egfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/egfp/product/Addgene inc
Average 94 stars, based on 1 article reviews
egfp - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

96
Addgene inc aav8 cmv egfp
KEY RESOURCES TABLE
Aav8 Cmv Egfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aav8 cmv egfp/product/Addgene inc
Average 96 stars, based on 1 article reviews
aav8 cmv egfp - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

Image Search Results


Fluorescence Images of Control and AAV2-, AAV5-, and AAV-8-Injected Eyes Whole mounts of control eyes with (E) or without (A) choroidal neovascularization (CNV) showed only faint autofluorescence around the optic nerve head. In the absence of CNV, eyes injected with AAV2 (B) demonstrated diffuse, scattered fluorescence spots throughout the fundus, while eyes injected with AAV5 (C) or AAV8 (D) showed less fluorescence. In eyes with CNV, transduction of AAV of all three serotypes—AAV2 (F), -5 (G), and -8 (H)—was markedly increased around CNV lesions. The increase in transduction of AAV2 was greater than that of the other two serotypes. (I) The relative fluorescence intensities were as follows: AAV2/CNV − (n = 5), 2.45 ± 0.24; AAV2/CNV + (n = 10), 3.93 ± 0.32; AAV5/CNV − (n = 5), 1.88 ± 0.17; AAV5/CNV + (n = 10), 3.20 ± 0.19; AAV8/CNV − (n = 5), 2.07 ± 0.21; AAV8/CNV + (n = 10), 3.43 ± 0.21 (I). In the absence of CNV, there were significant differences in fluorescence intensity between control eyes and eyes injected with AAV (AAV2/CNV − , AAV5/CNV − , and AAV8/CNV − ) (p < 0.05). The fluorescence intensity differed significantly between eyes with and without CNV injected with all of the three AAV serotypes (AAV2, p < 0.017; AAV5, p < 0.024; AAV8, p < 0.021). Data are expressed as mean ± SEM. Significant differences: †p < 0.05 versus control eyes, ‡p < 0.05 versus eyes without CNV. Asterisk (*), CNV lesion. Scale bars, 200 μm.

Journal: Molecular Therapy. Methods & Clinical Development

Article Title: Transduction Patterns of Adeno-associated Viral Vectors in a Laser-Induced Choroidal Neovascularization Mouse Model

doi: 10.1016/j.omtm.2018.01.008

Figure Lengend Snippet: Fluorescence Images of Control and AAV2-, AAV5-, and AAV-8-Injected Eyes Whole mounts of control eyes with (E) or without (A) choroidal neovascularization (CNV) showed only faint autofluorescence around the optic nerve head. In the absence of CNV, eyes injected with AAV2 (B) demonstrated diffuse, scattered fluorescence spots throughout the fundus, while eyes injected with AAV5 (C) or AAV8 (D) showed less fluorescence. In eyes with CNV, transduction of AAV of all three serotypes—AAV2 (F), -5 (G), and -8 (H)—was markedly increased around CNV lesions. The increase in transduction of AAV2 was greater than that of the other two serotypes. (I) The relative fluorescence intensities were as follows: AAV2/CNV − (n = 5), 2.45 ± 0.24; AAV2/CNV + (n = 10), 3.93 ± 0.32; AAV5/CNV − (n = 5), 1.88 ± 0.17; AAV5/CNV + (n = 10), 3.20 ± 0.19; AAV8/CNV − (n = 5), 2.07 ± 0.21; AAV8/CNV + (n = 10), 3.43 ± 0.21 (I). In the absence of CNV, there were significant differences in fluorescence intensity between control eyes and eyes injected with AAV (AAV2/CNV − , AAV5/CNV − , and AAV8/CNV − ) (p < 0.05). The fluorescence intensity differed significantly between eyes with and without CNV injected with all of the three AAV serotypes (AAV2, p < 0.017; AAV5, p < 0.024; AAV8, p < 0.021). Data are expressed as mean ± SEM. Significant differences: †p < 0.05 versus control eyes, ‡p < 0.05 versus eyes without CNV. Asterisk (*), CNV lesion. Scale bars, 200 μm.

Article Snippet: One microliter of AAV2-EGFP, AAV5-EGFP, and AAV8-EGFP (1 × 10 13 viral particles [vp]/ml) supplied by CdmoGen (Cheongju, Republic of Korea) were used for injection.

Techniques: Fluorescence, Injection, Transduction

Colocalization of EGFP with CD11b, F4/80, and CD31 in Eyes Injected with AAV5 and AAV8 AAV5 (arrowheads in A, A-1, B, and B-1) and AAV8 (arrowheads in D, D-1, E, and E-1) transduction was observed in CD11b − and F4/80 + cells in the subretinal space and the INL, but not in these cells in CNV lesions. A small proportion of CD31 + endothelial cells was also positive for EGFP (C, C-1, F, and F-1). Asterisk (*), CNV lesion. (A–F) Scale bars, 100 μm; and (A-1–F-1) scale bars, 50 μm.

Journal: Molecular Therapy. Methods & Clinical Development

Article Title: Transduction Patterns of Adeno-associated Viral Vectors in a Laser-Induced Choroidal Neovascularization Mouse Model

doi: 10.1016/j.omtm.2018.01.008

Figure Lengend Snippet: Colocalization of EGFP with CD11b, F4/80, and CD31 in Eyes Injected with AAV5 and AAV8 AAV5 (arrowheads in A, A-1, B, and B-1) and AAV8 (arrowheads in D, D-1, E, and E-1) transduction was observed in CD11b − and F4/80 + cells in the subretinal space and the INL, but not in these cells in CNV lesions. A small proportion of CD31 + endothelial cells was also positive for EGFP (C, C-1, F, and F-1). Asterisk (*), CNV lesion. (A–F) Scale bars, 100 μm; and (A-1–F-1) scale bars, 50 μm.

Article Snippet: One microliter of AAV2-EGFP, AAV5-EGFP, and AAV8-EGFP (1 × 10 13 viral particles [vp]/ml) supplied by CdmoGen (Cheongju, Republic of Korea) were used for injection.

Techniques: Injection, Transduction

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: Inactivation of medial entorhinal cortex selectively disrupts learning of interval timing

doi: 10.1016/j.celrep.2020.108163

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: ​ REAGENT or RESOURCE SOURCE IDENTIFIER Bacterial and Virus Strains AAV8.hSyn.Jaws-KGC.GFP-ER2.WPRE.hGH Addgene 65014-AAV8 pAAV8-hSyn-EGFP Addgene 50465-AAV8 Chemicals, Peptides, and Recombinant Proteins NeuroTrace 530/615 Red Fluorescent Nissl Stain Invitrogen {"type":"entrez-nucleotide","attrs":{"text":"N21482","term_id":"1126652","term_text":"N21482"}} N21482 NeuroTrace 435/455 Blue Fluorescent Nissl Stain Invitrogen {"type":"entrez-nucleotide","attrs":{"text":"N21479","term_id":"1126649","term_text":"N21479"}} N21479 Experimental Models: Organisms/Strains Mouse: C57-BL6 Charles River N/A Software and Algorithms MATALB Mathworks https://www.mathworks.com/products/matlab.html ; P-Clamp Axon Instruments www.moleculardevices.com Open in a separate window KEY RESOURCES TABLE Mice learn interval timing task and report duration through immobile waiting Optogenetic inactivation of MEC disrupts learning of interval timing behavior Learning deficit revealed by MEC inactivation specifically during timing behavior MEC inactivation did not significantly impair timing behavior after learning

Techniques: Recombinant, Staining, Software